Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
96.84 CHF | -2.25% |
|
-2.37% | +14.21% |
12:43pm | Novartis Q2 Core Earnings, Revenue Advance; 2024 Outlook Updated -- Shares Drop Pre-Bell | MT |
12:21pm | Novartis Lifts Full-Year Guidance on 'Strong Momentum' of Key Growth Drivers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.21% | 228B | |
+55.35% | 815B | |
+32.17% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.13% | 247B | |
+16.54% | 180B | |
+4.31% | 170B | |
+3.07% | 126B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG, Q4 2020 Earnings Call, Jan 26, 2021